16:55-17:10
观看视频
Long-term safety and activity of Humanized CD19-specific Chimeric Antigen Receptor T Cells for Acute Lymphoblastic Leukemia
17:10-17:25
观看视频
靶向CD70的CAR-T治疗AML临床前研究
17:25-17:40
观看视频
Chimeric Antigen Receptor T cell Targeting to CD19 and CD22 Combined with Anti-PD-1 Antibody Induce High Response in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma